Measuring inconsistency in meta-analyses
TLDR
A new quantity is developed, I 2, which the authors believe gives a better measure of the consistency between trials in a meta-analysis, which is susceptible to the number of trials included in the meta- analysis.Abstract:
Cochrane Reviews have recently started including the quantity I 2 to help readers assess the consistency of the results of studies in meta-analyses. What does this new quantity mean, and why is assessment of heterogeneity so important to clinical practice?
Systematic reviews and meta-analyses can provide convincing and reliable evidence relevant to many aspects of medicine and health care.1 Their value is especially clear when the results of the studies they include show clinically important effects of similar magnitude. However, the conclusions are less clear when the included studies have differing results. In an attempt to establish whether studies are consistent, reports of meta-analyses commonly present a statistical test of heterogeneity. The test seeks to determine whether there are genuine differences underlying the results of the studies (heterogeneity), or whether the variation in findings is compatible with chance alone (homogeneity). However, the test is susceptible to the number of trials included in the meta-analysis. We have developed a new quantity, I 2, which we believe gives a better measure of the consistency between trials in a meta-analysis.
Assessment of the consistency of effects across studies is an essential part of meta-analysis. Unless we know how consistent the results of studies are, we cannot determine the generalisability of the findings of the meta-analysis. Indeed, several hierarchical systems for grading evidence state that the results of studies must be consistent or homogeneous to obtain the highest grading.2–4
Tests for heterogeneity are commonly used to decide on methods for combining studies and for concluding consistency or inconsistency of findings.5 6 But what does the test achieve in practice, and how should the resulting P values be interpreted?
A test for heterogeneity examines the null hypothesis that all studies are evaluating the same effect. The usual test statistic …read more
Citations
More filters
Journal ArticleDOI
Cognitive behaviour therapy for chronic fatigue syndrome in adults
TL;DR: CBT is effective in reducing the symptoms of fatigue at post-treatment compared with usual care, and may be more effective in reduced fatigue symptoms compared with other psychological therapies, according to a review of 15 randomised controlled trials.
Journal ArticleDOI
Treatment of Brain Arteriovenous Malformations A Systematic Review and Meta-analysis
Janneke van Beijnum,H. Bart van der Worp,Dennis R. Buis,Rustam Al-Shahi Salman,L. Jaap Kappelle,Gabriel J.E. Rinkel,Jan Willem Berkelbach van der Sprenkel,W. Peter Vandertop,Ale Algra,Catharina J.M. Klijn +9 more
TL;DR: Although case fatality after treatment has decreased over time, treatment of brain AVM remains associated with considerable risks and incomplete efficacy, and Randomized controlled trials comparing different treatment modalities appear justified.
Journal ArticleDOI
Comparisons of Interventions for Preventing Falls in Older Adults: A Systematic Review and Meta-analysis.
Andrea C. Tricco,Andrea C. Tricco,Sonia M. Thomas,Areti Angeliki Veroniki,Jemila S. Hamid,Elise Cogo,Lisa Strifler,Lisa Strifler,Paul A. Khan,Reid Robson,Kathryn M. Sibley,Kathryn M. Sibley,Heather MacDonald,John J. Riva,Kednapa Thavorn,Kednapa Thavorn,Charlotte Wilson,Jayna Holroyd-Leduc,Gillian D. Kerr,Fabio Feldman,Sumit R. Majumdar,Susan B. Jaglal,Wing Hui,Sharon E. Straus,Sharon E. Straus +24 more
TL;DR: Exercise alone and various combinations of interventions were associated with lower risk of injurious falls compared with usual care, and choice of fall-prevention intervention may depend on patient and caregiver values and preferences.
Journal ArticleDOI
Statin Therapy and Risk of Developing Type 2 Diabetes: A Meta-Analysis
Swapnil Rajpathak,Dharam J. Kumbhani,Jill P. Crandall,Nir Barzilai,Michael H. Alderman,Paul M. Ridker +5 more
TL;DR: Although statin therapy greatly lowers vascular risk, including among those with and at risk for diabetes, the relationship ofstatin therapy to incident diabetes remains uncertain and future statin trials should be designed to formally address this issue.
Journal ArticleDOI
Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trials.
Adam A. Nishimura,Jantey Carey,Patricia J. Erwin,Jon C. Tilburt,M. Hassan Murad,Jennifer B. McCormick +5 more
TL;DR: Enhanced consent forms and extended discussions were most effective in improving participant understanding and Identification of best practices for studies of informed consent interventions would aid future systematic comparisons.
References
More filters
Journal ArticleDOI
Quantifying heterogeneity in a meta‐analysis
TL;DR: It is concluded that H and I2, which can usually be calculated for published meta-analyses, are particularly useful summaries of the impact of heterogeneity, and one or both should be presented in publishedMeta-an analyses in preference to the test for heterogeneity.
Journal ArticleDOI
The combination of estimates from different experiments.
TL;DR: The problem of making a combined estimate has been discussed previously by Cochran and Yates and Cochran (1937) for agricultural experiments, and by Bliss (1952) for bioassays in different laboratories as discussed by the authors.
Journal ArticleDOI
Tamoxifen for early breast cancer: An overview of the randomised trials
TL;DR: The absolute improvement in recurrence was greater during the first 5 years, whereas the improvement in survival grew steadily larger throughout the first 10 years, and these benefits appeared to be largely irrespective of age, menopausal status, daily tamoxifen dose, and of whether chemotherapy had been given to both groups.
Journal Article
Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group
TL;DR: There have been many randomised trials of adjuvant tamoxifen among women with early breast cancer, and an updated overview of their results is presented in this paper, which approximately doubles the amount of evidence from trials of about 5 years of tamoxifier and, taking all trials together, on events occurring more than 5 years after randomisation.
Journal ArticleDOI
Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis.
TL;DR: In this paper, the authors evaluated standard error, precision (inverse of standard error), variance, inverse of variance, sample size and log sample size (vertical axis) and log odds ratio, log risk ratio and risk difference (horizontal axis).